术后放疗对原发性颅内非典型脑膜瘤复发的影响
该研究回顾性分析了2007—2017年4个神经外科部门258例组织学诊断为原发性非典型脑膜瘤患者的病历,评估无进展生存期(PFS)及预后因素。结果显示术后放疗未改善PFS,最重要的预后因素仍是切除程度和年龄。
要点
- 术后放疗未改善原发性非典型脑膜瘤的PFS,倾向性评分匹配分析n=46,p=0.438。
- Simpson III-IV级切除与更短PFS相关(HR 1.19,95%CI 1.09-1.29,p<0.001)。
- 年龄>65岁与更短PFS相关(HR 2.89,95%CI 1.56-5.33,p=0.001)。
核心结论
- 在本研究中,术后放疗未改善PFS,最重要的预后因素仍是切除程度和年龄。
研究设计与样本
- 回顾性审查2007—2017年4个神经外科部门所有因组织学诊断的原发性非典型脑膜瘤接受手术患者的病历,以评估PFS和预后因素,共纳入258例患者。
主要发现
- 258例患者中位年龄60岁(54.7%为女性),肿瘤部位以凸面和大脑镰为主(60.9%),其次为颅底(37.2%)。
- Simpson I-II级切除194例(75.2%),Simpson III-IV级切除53例(20.5%);肿瘤进展54例(20.9%);术后放疗46例(17.8%)。
- 放疗更多用于不完全切除后(Simpson III-IV级37.7% vs Simpson I-II级13.4%)。
- 多因素分析显示Simpson III-IV级(HR 1.19,95%CI 1.09-1.29,p<0.001)和年龄>65岁(HR 2.89,95%CI 1.56-5.33,p=0.001)与更短PFS显著相关。
- 最短随访36个月的亚组分析显示,Simpson III-IV级(HR 3.01,95%CI 1.31-6.931.03-1.24,p=0.009)和年龄>65岁(HR 2.48,95%CI 1.20-5.13,p=0.014)降低PFS;原文此处95%CI写作1.31-6.931.03-1.24,原文此处表述有矛盾。
临床怎么用
- 作者结论指出术后放疗未改善PFS,最重要的预后因素仍是切除程度和年龄。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atypical meningiomas (WHO grade II) have high recurrence rate. However, data on the effect of radiotherapy (RT) is still conflicting. The aim of this study was to evaluate the influence of postoperative RT on the recurrence of primary atypical intracranial meningiomas. METHODS: The medical records of all patients who underwent surgery (2007-2017 in 4 neurosurgical departments) for a histologically diagnosed primary atypical meningioma were reviewed to assess progression-free survival (PFS) and prognostic factors. RESULTS: This analysis included 258 patients with a median age of 60 years (54.7% female). The predominant tumor locations were convexity and falx (60.9%) followed by the skull base (37.2%). Simpson grade I-II resection was achieved in 194 (75.2%) patients, Simpson grade III-IV in 53 patients (20.5%). Tumor progressed in 54 cases (20.9%). Postoperative RT was performed in 46 cases (17.8%). RT was more often applied after incomplete resection (37.7% vs. 13.4% Simpson III-IV vs. I-II). A multivariate analysis showed a significantly shorter PFS associated with Simpson III-IV [HR 1.19, (95% CI) 1.09-1.29, p < 0.001] and age > 65 years [HR 2.89, (95% CI) 1.56-5.33, p = 0.001]. A subgroup analysis with a minimal follow-up of 36 months revealed that Simpson III-IV [HR 3.01, 95% CI 1.31-6.931.03-1.24, p = 0.009] and age > 65 years [HR 2.48, 95% CI 1.20-5.13, p = 0.014] reduced PFS. The impact of postoperative RT on PFS remained statistically insignificant, even in a propensity-score matched survival analysis [n = 46; p = 0.438; OR 0.710 (0.299-1.687)]. CONCLUSIONS: In the present study, postoperative RT did not improve PFS. The most important prognostic factors remain the extent of resection and age.
引用
- Keric N, Kalasauskas D, Freyschlag CF, et al. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. J Neurooncol. 2020. PMID: 31900826. doi:10.1007/s11060-019-03382-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。